Bristol Myers Squibb Co. closed 3.24% short of its 52-week high of $61.10, which the company reached on January 27th.

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results tomorrow before the bell. Here’s what you ...

Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.

We recently published a list of 10 Best Wide Moat Stocks to Invest In. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best wide moat ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 17,611 calls trading, 2.0x expected, and implied vol increasing over 1 point to 29.73%. May-25 67.5 calls and Aug-25 45 puts are the ...

Jefferies analyst Akash Tewari maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) on February 3 and set a price target of ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Leading the elite Wall Street firm Cravath, he became a go-to adviser on mergers and acquisitions — “all the big deals that ...

Earnings season continues, with a diverse array of companies preparing to unveil their financial results for the upcoming trading day. Leading the charge are tech giant Amazon (NASDAQ:AMZN), video ...

Collegium Pharmaceutical , Inc. (NASDAQ:COLL), a pharmaceutical company with a market capitalization of nearly $1 billion and an impressive gross profit margin of 87%, announced on Monday the ...